Search research articles
Contact Us
Filters
Showing results (71-80 of 169) with videos related to
Page
of 17
Sort By:
Human Pathology
|
May 16, 2017
A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder
Kentaro Inamura, Maki Kobayashi, Hiroko Nagano, et al.
Pathology International
|
December 21, 2019
Mucinous lung adenocarcinoma, particularly referring to EGFR-mutated mucinous adenocarcinoma
Ryo Wakejima, Kentaro Inamura, Hironori Ninomiya, et al.
IJU Case Reports
|
January 6, 2023
A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome
Ryosuke Oki, Tetsuya Urasaki, Arisa Ueki, et al.
Abdominal Radiology (New York)
|
October 13, 2020
Is hypervascular papillary renal cell carcinoma present?
Tatsuya Yamamoto, Amori Gulanbar, Kuniyoshi Hayashi, et al.
Pathology, Research and Practice
|
February 4, 2020
Calretinin-expressing lung adenocarcinoma: Distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma
Masanori Matsuda, Hironori Ninomiya, Ryo Wakejima, et al.
Clinical Imaging
|
December 9, 2019
Identification of a specific ultrasonographic finding for differentiating hepatic angiomyolipoma from hepatocellular carcinoma
Katsuhiko Naito, Yasuyuki Shigematsu, Yoshimasa Fujiwara, et al.
Anticancer Research
|
August 28, 2025
The Significance of Phosphorylated Yes-associated Protein (YAP) (Ser 127) Expression in Oral Squamous Cell Carcinoma
Yusuke Amano, Daisuke Matsubara, Atsushi Kihara, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 11, 2020
Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma
Yasuhiro Nakashima, Kentaro Inamura, Hironori Ninomiya, et al.
Oncotarget
|
April 24, 2018
CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan
Yasuyuki Shigematsu, Kentaro Inamura, Yoshihiro Mise, et al.
International Journal of Clinical Oncology
|
September 16, 2019
Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer
Ryo Fujiwara, Kentaro Inamura, Takeshi Yuasa, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 169) with videos related to
Sort By:
Page
of 17
Human Pathology
|
May 16, 2017
A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder
Kentaro Inamura, Maki Kobayashi, Hiroko Nagano, et al.
Pathology International
|
December 21, 2019
Mucinous lung adenocarcinoma, particularly referring to EGFR-mutated mucinous adenocarcinoma
Ryo Wakejima, Kentaro Inamura, Hironori Ninomiya, et al.
IJU Case Reports
|
January 6, 2023
A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome
Ryosuke Oki, Tetsuya Urasaki, Arisa Ueki, et al.
Abdominal Radiology (New York)
|
October 13, 2020
Is hypervascular papillary renal cell carcinoma present?
Tatsuya Yamamoto, Amori Gulanbar, Kuniyoshi Hayashi, et al.
Pathology, Research and Practice
|
February 4, 2020
Calretinin-expressing lung adenocarcinoma: Distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma
Masanori Matsuda, Hironori Ninomiya, Ryo Wakejima, et al.
Clinical Imaging
|
December 9, 2019
Identification of a specific ultrasonographic finding for differentiating hepatic angiomyolipoma from hepatocellular carcinoma
Katsuhiko Naito, Yasuyuki Shigematsu, Yoshimasa Fujiwara, et al.
Anticancer Research
|
August 28, 2025
The Significance of Phosphorylated Yes-associated Protein (YAP) (Ser 127) Expression in Oral Squamous Cell Carcinoma
Yusuke Amano, Daisuke Matsubara, Atsushi Kihara, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 11, 2020
Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma
Yasuhiro Nakashima, Kentaro Inamura, Hironori Ninomiya, et al.
Oncotarget
|
April 24, 2018
CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan
Yasuyuki Shigematsu, Kentaro Inamura, Yoshihiro Mise, et al.
International Journal of Clinical Oncology
|
September 16, 2019
Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer
Ryo Fujiwara, Kentaro Inamura, Takeshi Yuasa, et al.
Page
of 17